Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508443 · ClinicalTrials.gov registry record · Phase 1
Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)
A Phase 1 study of Spinal Neoplasms, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00508443 is a Phase 1 study of Spinal Neoplasms that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00508443, a Phase 1 study of Spinal Neoplasms, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to find out if stereotactic spine radiotherapy is safe and effective in the treatment of metastatic spine tumors. The feasibility of this type of treatment will be studied as will any side effects related to the treatment. The precision and accuracy of the CT-on-rails will also be studied.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2002-10-25 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508443
The ClinicalTrials.gov registry entry for NCT00508443 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT00508443 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00508443 about?
NCT00508443 is a clinical study titled "Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)". The goal of this clinical research study is to find out if stereotactic spine radiotherapy is safe and effective in the treatment of metastatic spine tumors. The feasibility of this type of treatment will be studied as will any side effects related to the treatment. The precision and accuracy of the...
What is the current status of trial NCT00508443?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2002-10-25. Estimated completion is 2026-10-31.
What conditions does trial NCT00508443 study?
This clinical trial studies the following conditions: Spinal Neoplasms.
What interventions are being tested in trial NCT00508443?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00508443?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00508443 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.